Skip to main content
Year archive

ALTERITY THERAPEUTICS LIMITED — 2018 filings

All 32 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2018, sourced directly from the official regulator.

32 Filings
2018 Period
2018 filings (32)
Filing Released Lang
Life Bioscience LLC leads strategic investment upto A$44.5M 4 pages 237.7KB
Capital/Financing Update
2018-12-27 English
Trading Halt 2 pages 471.0KB
Regulatory Filings
2018-12-23 English
Form S-8 14 pages 279.1KB
Regulatory Filings
2018-12-04 English
2018 AGM Presentation 10 pages 635.6KB
AGM Information
2018-11-15 English
Results of Meeting 2 pages 192.1KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-15 English
Appendix 3B 11 pages 961.7KB
Capital/Financing Update
2018-11-15 English
Change of Director's Interest Notice - IS 2 pages 465.6KB
Director's Dealing
2018-11-15 English
Prana AGM Investor Conference Call 2 pages 759.1KB
AGM Information
2018-11-11 English
Appendix 4C - quarterly 5 pages 180.2KB
Interim / Quarterly Report
2018-10-29 English
Notice of Annual General Meeting/Proxy Form 25 pages 923.5KB
AGM Information
2018-10-16 English
New data show potential for PBT434 to treat MSA 2 pages 709.7KB
Regulatory Filings
2018-10-04 English
Form 20-F 127 pages 2.4MB
Annual Report
2018-09-02 English
Annual report 2018 on Form 20-F & XBRL data filed with SEC 1
Report Publication Announcement
2018-09-02 English
Appendix 4G 11 pages 124.4KB
Regulatory Filings
2018-08-30 English
Annual Report to shareholders 103 pages 2.5MB
Annual Report
2018-08-30 English
Preliminary Final Report 104 pages 2.6MB
Annual Report
2018-08-30 English
Appendix 4C - quarterly 5 pages 275.4KB
Interim / Quarterly Report
2018-07-30 English
Appendix 3B and 708A Notice 12 pages 254.5KB
Capital/Financing Update
2018-07-12 English
Prana to present PBT434 data at International Congress 2 pages 762.8KB
Regulatory Filings
2018-07-08 English
First Volunteers Dosed in Phase I Clinical Trial of PBT434 2 pages 209.1KB
Regulatory Filings
2018-07-03 English
Investor Presentation - Treatment of Neurological Disorders 34 pages 3.2MB
Investor Presentation
2018-06-26 English
Investor Presentation (amended) 34 pages 3.2MB
Investor Presentation
2018-06-26 English
Prana to commence Phase 1 clinical trial of PBT434 3 pages 726.0KB
Regulatory Filings
2018-06-13 English
Appendix 4C - quarterly 5 pages 265.2KB
Interim / Quarterly Report
2018-04-26 English
Prana to Present at the B. Riley FBR Symposium in China 2 pages 475.3KB
Regulatory Filings
2018-03-15 English
PBT434 at the 6th International Multiple System Atrophy Conf 2 pages 649.5KB
Regulatory Filings
2018-03-05 English
Half Yearly Report and Accounts 20 pages 286.4KB
Interim / Quarterly Report
2018-02-27 English
Form 6-K 19 pages 153.8KB
Interim / Quarterly Report
2018-02-27 English
Appendix 4C - quarterly 5 pages 713.6KB
Interim / Quarterly Report
2018-01-30 English
Appendix 3B 9 pages 826.8KB
Share Issue/Capital Change
2018-01-17 English
Investor Presentation - Treatment of Neurological Disorders 23 pages 2.7MB
Investor Presentation
2018-01-07 English
Dr. David Stamler presenting at Biotech Showcase 2 pages 471.2KB
Investor Presentation
2018-01-07 English